These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 1968270)

  • 1. Diuretic profile of 66A-078, a synthetic non hydrolizable dynorphin derivative active centrally.
    Donoso MV; Pérez A; López LF; Roblero J; Tachibana S; Huidobro-Toro JP
    Prog Clin Biol Res; 1990; 328():401-4. PubMed ID: 1968270
    [No Abstract]   [Full Text] [Related]  

  • 2. [N-methyl-Tyr1,N-methyl-Arg7-D-Leu8]-dynorphin-A-(1-8)ethylamide, a stable dynorphin analog, produces diuresis by kappa-opiate receptor activation in the rat.
    Salas SP; Roblero JS; López LF; Tachibana S; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1992 Sep; 262(3):979-86. PubMed ID: 1356155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [D-Pro10]-dynorphin(1-11) is a kappa-selective opioid analgesic in mice.
    Gairin JE; Gout R; Meunier JC; Cros J
    J Pharmacol Exp Ther; 1988 Jun; 245(3):995-1001. PubMed ID: 2898527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of atriopeptin in the hypotensive effect of dynorphin].
    Yin LY; Xie XZ; Gao XM; Xia ZQ; Xie CW; Tang J
    Sheng Li Xue Bao; 1988 Aug; 40(4):343-8. PubMed ID: 2907825
    [No Abstract]   [Full Text] [Related]  

  • 5. [D-Ala2, (F5) Phe4]-dynorphin 1-13-NH2 (DAFPHEDYN): a potent analog of dynorphin 1-13.
    Walker JM; Coy DH; Young EA; Baldrighi G; Siegel SF; Bowen WD; Akil H
    Peptides; 1987; 8(5):811-7. PubMed ID: 2893357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N,N-diallylated analogs of dynorphin A-(1-13) as potent antagonists for the endogenous peptide and selective kappa opioid analgesics.
    Lemaire S; Parent P; Lapierre C; Michelot R
    Prog Clin Biol Res; 1990; 328():45-8. PubMed ID: 1968273
    [No Abstract]   [Full Text] [Related]  

  • 7. Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity.
    Stevens CW; Yaksh TL
    J Pharmacol Exp Ther; 1986 Sep; 238(3):833-8. PubMed ID: 2875172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid receptors mediating the antinociceptive effect of dynorphin at spinal cord level.
    Spampinato S; Candeletti S; Romualdi P; Speroni E; Cavicchini E; Spadaro C; Murari G; Giobbi G; Ferri S
    Ann Ist Super Sanita; 1984; 20(1):99-102. PubMed ID: 6152521
    [No Abstract]   [Full Text] [Related]  

  • 9. ICI 174864, a putative delta opioid antagonist, reverses endotoxemic hypotension: pretreatment with dynorphin 1-13, A kappa agonist, blocks this action.
    Long JB; Ruvio BA; Glatt CE; Holaday JW
    Neuropeptides; 1984 Dec; 5(1-3):291-4. PubMed ID: 6152327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central and peripheral sites for cardiovascular actions of dynorphin-(1-13) in rats.
    Gautret B; Schmitt H
    Eur J Pharmacol; 1985 May; 111(2):263-6. PubMed ID: 2410282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid receptor activity in the dentate region of the rat hippocampus.
    Neumaier JF; Chavkin C
    NIDA Res Monogr; 1986; 75():101-4. PubMed ID: 2893261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diuretic effect of bremazocine, a kappa-opioid with central and peripheral sites of action.
    Salas SP; Roblero J; Ureta H; Huidobro-Toro JP
    J Pharmacol Exp Ther; 1989 Sep; 250(3):992-9. PubMed ID: 2550625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kappa opioid partial agonist activity of the enkephalin-like pentapeptide BW942C based on urination and in vitro studies in humans and animals.
    Vaupel DB; Cone EJ; Johnson RE; Su TP
    J Pharmacol Exp Ther; 1990 Jan; 252(1):225-34. PubMed ID: 2153801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of dynorphin A(1-17)-induced place preference in rats.
    Iwamoto ET
    NIDA Res Monogr; 1989; 95():308-9. PubMed ID: 2577037
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cholecystokinin octapeptide (CCK-8) antagonized analgesia mediated by mu and kappa opioid receptors].
    Wang XH; Wang XJ; Han JS
    Sheng Li Xue Bao; 1990 Jun; 42(3):219-25. PubMed ID: 1982023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynorphin A (1-13) and responsiveness of the newborn rat to a surrogate nipple: immediate behavioral consequences and reinforcement effects in conditioning.
    Petrov ES; Nizhnikov ME; Varlinskaya EI; Spear NE
    Behav Brain Res; 2006 Jun; 170(1):1-14. PubMed ID: 16621051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
    Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
    J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal alkylated derivatives of [D-Pro10]dynorphin A-(1-11) are highly selective for kappa-opioid receptors.
    Choi H; Murray TF; DeLander GE; Caldwell V; Aldrich JV
    J Med Chem; 1992 Nov; 35(24):4638-9. PubMed ID: 1361580
    [No Abstract]   [Full Text] [Related]  

  • 19. Dynorphin A (1-13): in vivo opioid antagonist actions and non-opioid anticonvulsant effects in the rat flurothyl test.
    Tortella FC; Holaday JW
    NIDA Res Monogr; 1986; 75():539-42. PubMed ID: 2893282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats.
    Bals-Kubik R; Ableitner A; Herz A; Shippenberg TS
    J Pharmacol Exp Ther; 1993 Jan; 264(1):489-95. PubMed ID: 8093731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.